heart failure with preserved EF (HFpEF)

introduction

patients with heart failure who have LVEF > 49%
- see heart failure with reduced ejection fraction (HFrEF) for Mx of those with LVEF < 50%
HFpEF prevalence is increasing and now accounts for ~50% of patients with heart failure in Australia
symptoms are mainly impaired exercise tolerance
mainly affects older, obese women and those with atrial fibrillation or hypertension
currently no useful drug Rx but a SGLT2 inhibitor (empagliflozin) should be considered in these patients to help prevent deterioration